Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

IL-36R ligands are potent regulators of dendritic and T cells.

Vigne S, Palmer G, Lamacchia C, Martin P, Talabot-Ayer D, Rodriguez E, Ronchi F, Sallusto F, Dinh H, Sims JE, Gabay C.

Blood. 2011 Nov 24;118(22):5813-23. doi: 10.1182/blood-2011-05-356873. Epub 2011 Aug 22.

2.

Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity.

Towne JE, Renshaw BR, Douangpanya J, Lipsky BP, Shen M, Gabel CA, Sims JE.

J Biol Chem. 2011 Dec 9;286(49):42594-602. doi: 10.1074/jbc.M111.267922. Epub 2011 Sep 29.

3.

Biology of IL-36 cytokines and their role in disease.

Gresnigt MS, van de Veerdonk FL.

Semin Immunol. 2013 Dec 15;25(6):458-65. doi: 10.1016/j.smim.2013.11.003. Epub 2013 Dec 17. Review.

PMID:
24355486
4.

Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs.

Towne JE, Garka KE, Renshaw BR, Virca GD, Sims JE.

J Biol Chem. 2004 Apr 2;279(14):13677-88. Epub 2004 Jan 20.

5.

TLR ligands can activate dendritic cells to provide a MyD88-dependent negative signal for Th2 cell development.

Sun J, Walsh M, Villarino AV, Cervi L, Hunter CA, Choi Y, Pearce EJ.

J Immunol. 2005 Jan 15;174(2):742-51.

7.

IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin.

Foster AM, Baliwag J, Chen CS, Guzman AM, Stoll SW, Gudjonsson JE, Ward NL, Johnston A.

J Immunol. 2014 Jun 15;192(12):6053-61. doi: 10.4049/jimmunol.1301481. Epub 2014 May 14.

8.

Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.

Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KH.

Immunity. 2009 Aug 21;31(2):331-41. doi: 10.1016/j.immuni.2009.08.001. Epub 2009 Aug 13.

9.

Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation.

Morelli AE, Zahorchak AF, Larregina AT, Colvin BL, Logar AJ, Takayama T, Falo LD, Thomson AW.

Blood. 2001 Sep 1;98(5):1512-23.

10.

The severity of experimental arthritis is independent of IL-36 receptor signaling.

Lamacchia C, Palmer G, Rodriguez E, Martin P, Vigne S, Seemayer CA, Talabot-Ayer D, Towne JE, Gabay C.

Arthritis Res Ther. 2013 Mar 1;15(2):R38. doi: 10.1186/ar4192.

11.

Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88.

Yang R, Murillo FM, Cui H, Blosser R, Uematsu S, Takeda K, Akira S, Viscidi RP, Roden RB.

J Virol. 2004 Oct;78(20):11152-60.

12.

IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo.

Scheibe K, Backert I, Wirtz S, Hueber A, Schett G, Vieth M, Probst HC, Bopp T, Neurath MF, Neufert C.

Gut. 2017 May;66(5):823-838. doi: 10.1136/gutjnl-2015-310374. Epub 2016 Jan 18.

PMID:
26783184
14.

IL-1F5 mediates anti-inflammatory activity in the brain through induction of IL-4 following interaction with SIGIRR/TIR8.

Costelloe C, Watson M, Murphy A, McQuillan K, Loscher C, Armstrong ME, Garlanda C, Mantovani A, O'Neill LA, Mills KH, Lynch MA.

J Neurochem. 2008 Jun;105(5):1960-9. doi: 10.1111/j.1471-4159.2008.05304.x. Epub 2008 Feb 18.

15.

Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.

Boutet MA, Bart G, Penhoat M, Amiaud J, Brulin B, Charrier C, Morel F, Lecron JC, Rolli-Derkinderen M, Bourreille A, Vigne S, Gabay C, Palmer G, Le Goff B, Blanchard F.

Clin Exp Immunol. 2016 May;184(2):159-73. doi: 10.1111/cei.12761. Epub 2016 Feb 22.

16.

Prostaglandin I2 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells.

Zhou W, Hashimoto K, Goleniewska K, O'Neal JF, Ji S, Blackwell TS, Fitzgerald GA, Egan KM, Geraci MW, Peebles RS Jr.

J Immunol. 2007 Jan 15;178(2):702-10.

17.

Functional heterogeneity among bone marrow-derived dendritic cells conditioned by T(h)1- and T(h)2-biasing cytokines for the generation of allogeneic cytotoxic T lymphocytes.

Sato M, Iwakabe K, Ohta A, Sekimoto M, Nakui M, Koda T, Kimura S, Nishimura T.

Int Immunol. 2000 Mar;12(3):335-42.

PMID:
10700468
18.

IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist.

van de Veerdonk FL, Stoeckman AK, Wu G, Boeckermann AN, Azam T, Netea MG, Joosten LA, van der Meer JW, Hao R, Kalabokis V, Dinarello CA.

Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3001-5. doi: 10.1073/pnas.1121534109. Epub 2012 Feb 6.

19.
20.

Adhesive substrates modulate the activation and stimulatory capacity of non-obese diabetic mouse-derived dendritic cells.

Acharya AP, Dolgova NV, Xia CQ, Clare-Salzler MJ, Keselowsky BG.

Acta Biomater. 2011 Jan;7(1):180-92. doi: 10.1016/j.actbio.2010.08.026. Epub 2010 Aug 31.

PMID:
20807596

Supplemental Content

Support Center